Rasburicase and Tumor Lysis Syndrome: Lower Dosage, Consideration of Indications, and Hyperhydration
Author:
Affiliation:
1. Saint-Etienne Teaching Hospital, Saint-Etienne, France
2. Avicenne Teaching Hospital, Bobigny, France
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.32.6751
Reference14 articles.
1. Control of Plasma Uric Acid in Adults at Risk for Tumor Lysis Syndrome: Efficacy and Safety of Rasburicase Alone and Rasburicase Followed by Allopurinol Compared With Allopurinol Alone—Results of a Multicenter Phase III Study
2. Treatment of Impending Tumor Lysis with Single-Dose Rasburicase
3. Single-Dose Rasburicase 6 mg in the Management of Tumor Lysis Syndrome in Adults
4. A single dose of rasburicase is sufficient for the treatment of hyperuricemia in patients receiving chemotherapy
5. Reduced-dose rasburicase (recombinant xanthine oxidase) in adult cancer patients with hyperuricemia
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era;International Journal of Hematology;2024-04-05
2. Cofactor-Free Dioxygenases-Catalyzed Reaction Pathway via Proton-Coupled Electron Transfer;The Journal of Physical Chemistry B;2022-12-16
3. Hyperleucocytosis in children with acute mieloid leukemia;Pediatric Hematology/Oncology and Immunopathology;2020-03-28
4. Risk-based management strategy and outcomes of tumor lysis syndrome in children with leukemia/lymphoma: Analysis from a resource-limited setting;Pediatric Blood & Cancer;2018-08-12
5. Metabolische Entgleisungen als paraneoplastische Syndrome;Der Internist;2017-11-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3